"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

Considerable scale-up is needed to achieve the 2025 goals for HIV pre-exposure prophylaxis (PrEP), according to study findings.

On Worlds AIDS Day, the benefits of PEPFAR, PrEP, and U=U are celebrated. But continuing stigma and decreasing political will ...

Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Approved by the FDA 12 years ago, pre-exposure prophylaxis (PrEP) has significantly reduced the risk of HIV transmission and ...

A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...

As medical scientists working in HIV prevention, we believe that HIV vaccines will be critical to eliminating HIV ...

Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the ...

Cidara Therapeutics (CDTX) announced it has reached full planned enrollment of 5,000 subjects in the Phase 2b NAVIGATE trial across clinical ...

But Woodward said the increase could be slowed down if there was greater uptake in drugs that prevent HIV transmission, ...

Yesterday, World AIDS Day, Bay Area church services acknowledged lives lost in the HIV/AIDS pandemic and elected officials ...